Latest Cognis Stories
LITTLE FALLS, N.J., Aug.
LUDWIGSHAFEN, Germany, June 23 /PRNewswire/ -- BASF SE has reached an agreement with Cognis Holding Luxembourg S.a r.l. controlled by Permira Funds, GS Capital Partners and SV Life Sciences to acquire the specialty chemicals company Cognis for an equity purchase price of euro 700 million.
NATICK, Mass., April 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has received U.S.
NEW YORK, March 17 /PRNewswire/ -- Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market specialty industrial, healthcare and financial services companies, today announced that it has entered into a definitive agreement with Eastman Chemical Company (NYSE: EMN) to sell its portfolio company Genovique Specialties Corporation, a leading global provider of benzoate plasticizers. Genovique Specialties, headquartered in Rosemont, IL, is a global...
Group Aims to Curb Misleading Use of 'Natural' WASHINGTON Feb.
LONDON, Dec. 9 /PRNewswire/ -- The 2009 Frost & Sullivan Green Excellence of the Year Award in the field of adhesives for mobile electronics is presented to Henkel AG & Co. KGaA in recognition of the company's development of the LoctiteÂ® Halogen-Free range of products.
NEW YORK, Dec.
NEW YORK, Nov.
NEW YORK, Nov.
-- The move from synthetic ingredients to more "natural" ingredients should be regarded as a driver for cosmetic and toiletry ingredients market. -- LITTLE FALLS, N.J., Feb.
- A person in a secondary role, specifically the second most important character (after the protagonist).